Federal Register / Vol. 71, No.

143 / Wednesday, July 26, 2006 / Notices 42405

TABLE I—Continued
Approximate Application due Approx. grant
States/populations/areas to be served funding available date funding date

Region IX:
Navajo Nation ........................................................................................................... 640,000 03/01/07 07/01/07
Commonwealth of the Northern Mariana Islands .................................................... 170,000 09/01/06 01/01/07
Federated States of Micronesia ............................................................................... 411,000 03/01/07 07/01/07
Nevada, Washoe County ......................................................................................... 708,000 03/01/07 07/01/07
Region X:
Alaska ....................................................................................................................... 420,000 03/01/07 07/01/07
Oregon ...................................................................................................................... 2,452,000 03/01/07 07/01/07
Idaho ......................................................................................................................... 1,568,000 03/01/07 07/01/07
Washington ............................................................................................................... 3,240,000 09/01/06 01/01/07
Washington, Seattle area ......................................................................................... 159,000 03/01/07 07/01/07

Dated: July 19, 2006. DEPARTMENT OF HEALTH AND 8456, e-mail

Evelyn M. Kappeler, HUMAN SERVICES jholmberg@osophs.dhhs.gov.
Acting Director, Office of Population Affairs. SUPPLEMENTARY INFORMATION: Public
Meeting of the Advisory Committee on
[FR Doc. E6–11963 Filed 7–25–06; 8:45 am] comment will be solicited at the
Blood Safety and Availability
BILLING CODE 4150–34–P meeting and will be limited to five
AGENCY: Office of Public Health and minutes per speaker. Individuals who
Science, Office of the Secretary, DHHS. wish to present comments to the
DEPARTMENT OF HEALTH AND ACTION: Notice. Committee should contact the Executive
HUMAN SERVICES Secretary to register no later than close
SUMMARY: As stipulated by the Federal of business on August 25, 2006.
Office of the National Coordinator; Advisory Committee Act, the U.S. Individuals who wish to have printed
American Health Information Department of Health and Human material distributed are encouraged to
Community Biosurveillance Data Services is hereby giving notice that the provide thirty (30) copies to the
Steering Group Meeting Advisory Committee on Blood Safety Executive Secretary no later than close
and Availability (ACBSA) will hold a of business August 25, 2006. Likewise,
meeting. The ACBSA will meet to those who wish to utilize electronic data
ACTION: Announcement of meeting. review progress and solicit additional projection to the Committee must
input regarding numerous submit their materials to the Executive
SUMMARY: This notice announces the recommendations made during the past
third meeting of the American Health Secretary prior to close of business
year, specifically biovigilance of blood August 25, 2006.
Information Community Biosurveillance components and its derivatives, cells,
Data Steering Group in accordance with tissues, and organs. Vigilance is Dated: July 20, 2006.
the Federal Advisory Committee Act recognized as a necessary step in Jerry A. Holmberg,
(Pub. L. No. 92–463, 5 U.S.C., App.). monitoring outcomes in a quality Executive Secretary, Advisory Committee on
assurance process toward the goal of Blood Safety and Availability.
DATES: August 8, 2006 from 2 p.m. to 4 [FR Doc. E6–11962 Filed 7–25–06; 8:45 am]
providing safe and available biological
p.m.
products (i.e., blood components and BILLING CODE 4150–41–P
ADDRESSES: Mary C. Switzer Building derivatives, cells, tissues and organs)
(330 C Street, SW., Washington, DC and improvement of care of the donor
20201), Conference Room 4090 (you and recipient. Elements necessary for DEPARTMENT OF HEALTH AND
will need a photo ID to enter a Federal vigilant surveillance are detection, HUMAN SERVICES
building). analysis, reporting, utilizations,
research, education, and management of Food and Drug Administration
FOR FURTHER INFORMATION CONTACT: outcomes, including emerging or re- [Docket No. 2006O–0231]
http://www.hhs.gov/healthit/ahic.html. emerging infectious and non-infectious
SUPPLEMENTARY INFORMATION: The events of transfusion and/or Over-the-Counter Drug Products;
meeting will be available via Internet transplantation, will be discussed. Safety and Efficacy Review; Additional
DATES: The meeting will take place Sunscreen Ingredient
access. Go to http://www.hhs.gov/
healthit/ahic.html for additional Wednesday, August 30 and Thursday, AGENCY: Food and Drug Administration,
information on the meeting. August 31, 2006 from 9 a.m. to 5 p.m. HHS.
ADDRESSES: Marriott Crystal Gateway,
Dated: July 19, 2006. ACTION: Notice of eligibility; request for
1700 Jeff Davis Highway, Arlington, VA data and information.
Judith Sparrow, 22202.
Director, American Health Information FOR FURTHER INFORMATION CONTACT: Jerry SUMMARY: The Food and Drug
Community, Office of Programs and A. Holmberg, PhD, Executive Secretary, Administration (FDA) is announcing a
Coordination, Office of the National Advisory Committee on Blood Safety call-for-data for safety and effectiveness
sroberts on PROD1PC70 with NOTICES

Coordinator for Health Information and Availability, Office of Public Health information on the following condition
Technology.
and Science, Department of Health and as part of FDA’s ongoing review of over-
[FR Doc. 06–6485 Filed 7–25–06; 8:45am] Human Services, 1101 Wootton the-counter (OTC) drug products:
BILLING CODE 4150–24–M Parkway, Room 250, Rockville, MD Diethylhexyl butamido triazone, up to 3
20852, (240) 453–8809, fax (240) 453– percent, as a sunscreen single active

VerDate Aug<31>2005 17:16 Jul 25, 2006 Jkt 208001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\26JYN1.SGM 26JYN1